腹腔镜下肝部分切除术治疗原发性肝癌患者外周血T淋巴细胞亚群和血清细胞因子水平的变化*

doi:10.3969/j.issn.1672-5069.2018.05.025

摘要/Abstract

摘要： 目的探讨腹腔镜肝部分切除术治疗原发性肝癌（PLC）患者外周血T淋巴细胞亚群和血清细胞因子水平的变化。方法 2014年2月~2015年2月于我院治疗的PLC患者68例,采用随机数字表法分为腔镜组34例和开腹组34例,分别在不同方式下行肝肿瘤切除术。采用免疫浊度法检测血清IgG、IgA、IgM含量,采用酶联免疫吸附法检测血清血管内皮生长因子（VEGF）、成纤维细胞生长因子（aFGF）和bFGF水平,使用流式细胞仪检测外周血CD3⁺、CD4⁺和CD8⁺T细胞百分比。结果术前,两组外周血CD3⁺、CD4⁺、CD8⁺T细胞百分比无显著性差异（P>0.05）,术后7 d,腔镜组CD3⁺、CD4⁺、CD8⁺T细胞百分比分别为（57.2±5.6） %、（46.9±7.2）%和（28.4±5.3） %,与开腹组比,存在显著性差异【分别为（51.9±3.2） %、（41.2±6.4） %和（33.6±2.3） %,P<0.05】;血清VEGF、aFGF和bFGF水平分别为（18.4±5.1） ng/ml、（5.3±4.2） pg/ml和（6.5±4.3） pg/ml,显著低于开腹组【分别为（31.9±5.7）ng/ml、（8.7±5.2） pg/ml和（8.4±6.9） pg/ml,P<0.05】;两组肝功能指标和血清免疫球蛋白水平变化无显著性差异（P>0.05）。结论腹腔镜下肝切除术与开腹肝切除术治疗PLC患者比,可能因为创伤小而对机体的免疫功能影响较小。

关键词: 原发性肝癌, 腹腔镜下肝切除术, T细胞亚群, 细胞因子

Abstract: Objective To investigate the effect of 1aparoscopic hepatectomy on peripheral blood T lymphocyte subsets and serum cytokines in patients with primary liver cancer（PLC）. Methods 68 patients with PLC were recruited in our hospital between February 2014 and February 2015,and were randomly divided into two groups with 34 in each. 34 patients received laparoscopic hepatectomy and another 34 received open hepatectomy. The peripheral blood T lymphocyte subsets and serum cytokines,immunoglobulin levels were assayed and compared between the two groups. Results The percentages of peripheral blood CD3⁺,CD4⁺ and CD8⁺T cells in the two groups at presentation were not significantly different（P>0.05）,while the CD3⁺,CD4⁺ and CD8⁺T cells in patients receiving laparoscopic hepatectomy seven days after operation were（57.2±5.6）%,（46.9±7.2）% and （28.4±5.3） %,significantly different as compared to[（51.9±3.2）%,（41.2±6.4）% and（33.6±2.3）%] in open hepatectomy,respectively,（P<0.05）;serum vascular endothelial growth factor（VEGF）,fibroblast growth factors-a （aFGF） and bFGF levels were （18.4±5.1） ng/ml,（5.3±4.2） pg/ml and （6.5±4.3） pg/ml,much lower than [（31.9±5.7） ng/ml,（8.7±5.2） pg/ml and（8.4±6.9） pg/ml,respectivley,in open hepatectomy,P<0.05];the changes of blood liver function index and immumoglobulin levels in the two groups were not significantly different（P>0.05）. Conclusion The impact of laparoscopic hepatectomy on immune functions is milder than open operation, might be related to its mild injuries in the process.

Key words: Hepatoma, Laparoscopy hepetectomy, Peripheral blood T lymphocyte subsets, Vascular endothelial growth factor, Fibroblast growth factors

王全晖, 张元浩, 袁守信, 乔师师. 腹腔镜下肝部分切除术治疗原发性肝癌患者外周血T淋巴细胞亚群和血清细胞因子水平的变化^*[J]. 实用肝脏病杂志, 2018, 21(5): 753-756.

Wang Quanhui, Zhang Yuanhao, Yuan Shouxin, et al.. Effect of 1aparoscopic hepatectomy on peripheral blood T lymphocyte subsets and serum cytokines in patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2018, 21(5): 753-756.

参考文献

[1] 江现强,俞渊,陆世锋,等. 腹腔镜肝叶切除术常见并发症的危险因素分析及临床处理. 实用肝脏病杂志,2017,20(2):215-218.
[2] Sugawara Y,Inomata Y. Indications for living donor liver transplantation in patients with hepatocellular carcinoma. Hepatobiliary Surg Nutrit,2016,5:429-432.、
[3] 张跃伟. 微创介入治疗肝癌对机体免疫功能影响的研究现状与展望. 实用肝脏病杂志,2014,17(3):231-233,234.
[4] Kalathil S,Lugade AA,Miller A,et al.Higher frequencies of GARP+ CTLA-4+ Foxp3+T regulatory cells and myeloid-derived suppressor cells in hepatocellular carcinoma patients are associated with impaired T cell functionality. Cancer Res,2013,73:2435-2444.
[5] Yu SJ.A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world:2010-2016. Clin Mol Hepatol,2016,22:7-17.
[6] Yau T,Tang VYF,Yao TJ,et al.Development of Hong Kong liver cancer staging system with treatment stratification for patients with hepatocellular carcinoma. Gastroenterology,2014,146:1691-1700.
[7] Ju DY,Nakamura I,Roberts LR.The tumor microenvironment in hepatocellular carcinoma:Current status and therapeutic targets. Sem Cancer Biol,2011,21:35-43.
[8] Shah DR,Green S,Elliot A,et al.Current oncologic applications of radiofrequency ablation therapies. World J Gastrointest Oncol,2013,5:71-80.
[9] Yi Y,He HW,Wang JX,et al. The functional impairment of HCC-infiltrating γδ T cells,partially mediated by regulatory T cells in a TGFβ-and IL-10-dependent manner. J Hepatol,2013,58:977.、
[10] 吕永祥,郑伟. 腹腔镜肝切除联合微波消融治疗肝细胞癌患者疗效及安全性评价. 实用肝脏病杂志,2016,19(6):692-695.
[11] Bang JS,Kim SH,Yang SH.Ileal perforation with diaphragmatic injury after radiofrequency ablation for hepatocellular carcinoma. Tur J Gastroenterol,2016,27:202.
[12] Fuster J.Surgical treatment of hepatocellular carcinoma:should resection be performed according to Barcelona Clinic Liver Cancer Classification. Surg Today,2015,2(3):245-253.
[13] Bacalbasa N,Balescu I,Tomescu D.Partial cystectomy with distal ureteral resection and re-implantation for locally invasive cervical cancer. Anticancer Res,2015,35(10):5539-5542.
[14] Zhang Y,Huang F,Wang J,et al.MiR-15b mediates liver cancer cells proliferation through targeting BCL-2. Int J Clin Exp Pathol,2015,8(12):15677.
[15] Mehta A,Herrera H,Block T.Chapter seven-glycosylation and liver cancer. Adv Cancer Res,2015,126:257-279.
[16] Robertson CL, Srivastava J,Rajasekaran D,et al.The role of AEG-1 in the development of liver cancer. Hepat Oncol,2015,2(3):303.
[17] Cho Y S,Shin M S,Ko I G,et al.Ulinastatin inhibits cerebral ischemia-induced apoptosis in the hippocampus of gerbils. Mol Med Rep NLM,2015,12(2):1796.
[18] Prajapati HJ,Kim HS.Development of the new prognostic staging system(SS) in patients with unresectable hepatocellular carcinoma (HCC):multivariate survival analysis (MVA)-superior than Okuda,CLIP,BCLC,and Hong Kong Liver Cancer(HKLC) SSs. J Vasc Interv Radiol,2015,26(2):S66-S67.
[19] Michele G,Chiara B.Non-coding RNAs in primary liver cancer. Front Med,2015,2(2):36.
[20] Alakilli SYM,Mahrous KF.Evaluation of the chemopreventive impacts of lactoferrin on the initiation of liver cancer induced by diethylnitrosamine in male mice. IJPSRR,2015,32(2):59-66.
[21] Yang B,Gao M,Wang K,et al.Intraintestinal administration of ulinastatin protects against sepsis by relieving intestinal damage. J Surg Res,2017,211(1):70-78.

腹腔镜下肝部分切除术治疗原发性肝癌患者外周血T淋巴细胞亚群和血清细胞因子水平的变化^*

Effect of 1aparoscopic hepatectomy on peripheral blood T lymphocyte subsets and serum cytokines in patients with primary liver cancer

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	闵峰, 黄文琪, 吴卫兵, 张丽, 范荣华. 慢性乙型肝炎患者血清脂肪细胞因子水平变化及其临床意义^*[J]. 实用肝脏病杂志, 2019, 22(6): 824-827.
[2]	杨才勇, 陈娜, 李奎, 江自成, 卜蓉蓉. 慢性丙型肝炎和丙型肝炎肝硬化患者外周血Treg和Th17水平变化临床意义探讨^*[J]. 实用肝脏病杂志, 2019, 22(6): 868-871.
[3]	邢昊, 韩骏, 杨田. 应用血清PIVKA-II诊断肝细胞癌研究进展^*[J]. 实用肝脏病杂志, 2019, 22(6): 934-937.
[4]	赵协山, 伍春瑢, 王春峰, 余积洁, 何青. 替诺福韦联合安络化纤丸治疗HBeAg阴性慢性乙型肝炎患者疗效及其血清肝纤维化指标的变化研究*[J]. 实用肝脏病杂志, 2019, 22(5): 644-647.
[5]	刘杏, 赵树立, 张殿隆. 七氟烷吸入时机对肝脏部分切除术患者肝脏缺血再灌注损伤的影响*[J]. 实用肝脏病杂志, 2019, 22(5): 728-731.
[6]	延喜胜, 李伟, 王剑. 酒精性肝病患者血清细胞因子水平和肠道菌群分布变化研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 518-521.
[7]	严玲玲, 胡东辉, 黄艳芳. 腺苷蛋氨酸联合多烯磷酯酰胆碱治疗妊娠期肝内胆汁淤积症患者临床疗效初步研究^*[J]. 实用肝脏病杂志, 2019, 22(4): 530-533.
[8]	王媛, 党盼玉, 王伟. 血浆置换联合连续性血浆透析滤过治疗慢加急性肝衰竭患者临床疗效及其对血浆细胞因子水平的影响[J]. 实用肝脏病杂志, 2019, 22(4): 541-544.
[9]	崔发强, 李涛, 王铮, 陈青. 原发性肝癌患者外周血KRAS基因水平及其对西妥昔单克隆抗体治疗疗效的影响[J]. 实用肝脏病杂志, 2019, 22(4): 565-568.
[10]	赵晓光, 史玉洁. 应用还原型谷胱甘肽预防处理接受TACE治疗的中晚期原发性肝癌患者对肝功能的影响[J]. 实用肝脏病杂志, 2019, 22(3): 425-428.
[11]	李克田,沈明格,王凤荣,胡春荣,曹玉杰,芦鹏. 血糖水平对原发性肝癌患者¹⁸F-FDG摄取和PET/CT检查图像质量的影响研究^*[J]. 实用肝脏病杂志, 2019, 22(2): 256-259.
[12]	王禅, 秦伟, 戴勇, 李晓峰, 张成强. 自体外周血干细胞移植治疗乙型肝炎肝硬化患者临床疗效及其对外周血T淋巴细胞亚群的影响[J]. 实用肝脏病杂志, 2019, 22(1): 97-100.
[13]	王翠晓, 高静. 血清高尔基蛋白73、甲胎蛋白异质体3、甲胎蛋白和α-L-岩藻糖苷酶水平诊断原发性肝癌的效能分析^*[J]. 实用肝脏病杂志, 2019, 22(1): 113-116.
[14]	陈向, 汪宝林, 吴琛, 唐劲草, 张弛, 褚朝顺. 动脉灌注化疗栓塞联合放射粒子植入治疗原发性肝癌患者疗效及其对肝组织TRF1和TRF2表达的影响^*[J]. 实用肝脏病杂志, 2019, 22(1): 121-124.
[15]	闫书鸣, 王建国, 李泽信, 游焜, 王亮, 郭鹏威. 门冬氨酸鸟氨酸治疗肝癌切除术患者对肝脏缺血再灌注损伤的保护作用研究^*[J]. 实用肝脏病杂志, 2018, 21(6): 932-935.